Caption Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Caption Management’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-56,010	Closed	-$1.41M	–	1848
2022 Q3	$1.41M	Buy	+56,010	New	+$1.55M	0.02%	757
2022 Q1	–	Sell	-99,900	Closed	-$2.96M	–	2096
2021 Q4	$2.63M	Buy	+99,900	New	+$7.73M	0.03%	686
2021 Q2	–	Sell	-4,500	Closed	-$450K	–	1646
2021 Q1	$450K	Buy	+4,500	New	+$525K	0.01%	833
2020 Q3	–	Sell	-39,100	Closed	-$4.89M	–	1330
2020 Q2	$6.1M	Buy	39,100 +26,200	+203%	+$3.98M	0.2%	133
2020 Q1	$1.86M	Sell	12,900 -22,516	-64%	-$4.35M	0.11%	274
2019 Q4	$7.24M	Buy	+35,416	New	+$6.46M	0.24%	99

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's RETA Position: Q4 2022 in Review

Caption Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q4 2022, closing a stake of 56,010 shares — an estimated $1.41M sold.

Caption Management first reported a position in RETA in Q4 2019 and held it in 6 quarters. The position peaked at $7.24M in Q4 2019. 168 funds tracked by Wall St. Rank hold RETA as of Q4 2022.

Caption Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Caption Management sold 56,010 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q4 2022, an estimated $1.41M.
Caption Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2019 and held it in 6 quarters.
Caption Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $7.24M in Q4 2019.
168 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.